Risk Assessment of Adverse Outcomes in Symptomatic Patients With Arterial Hypertension and Chronic Heart Failure With Preserved Ejection Fraction Using THE HFA-PEFF Algorithm

Aim      To study the incidence of heart failure (HF) in patients with arterial hypertension (AH), symptoms of HF, and left ventricular ejection fraction (LV EF) ≥50 % using a novel, modified HFA-PEFF diagnostic algorithm and to evaluate the liver hydration status and density depending on the established HF profiles and the prognostic significance of this algorithm.

Material and methods  This study included 180 patients (median age, 72 years) with AH, symptoms of HF, and LV EF ≥50 %. The incidence of chronic HF with preserved ejection fraction (CHFpEF) was studied with the stepwise, modified HFA-PEFF diagnostic algorithm, and long-term outcomes were assessed at 3, 6, and 12 months of follow-up. The hydration status was determined by a bioimpedance vector analysis, and the liver density was measured by indirect fibroelastometry. The following tests were performed for all patients: standard, general clinical and laboratory examination with evaluation of CH symptoms (including N-terminal pro-brain natriuretic peptide test); extended echocardiography with assessment of structural and functional parameters of the heart; a KCCQ questionnaire was used for evaluation of patients’ condition and quality of life (QoL). Long-term outcomes were studied by phone calls at 3, 6, and 12 months following discharge from the hospital/visit (worsened QoL, repeated hospitalization for cardiovascular causes, cardiovascular death or all-cause death).

Results The following profiles were determined by the HFA-PEFF algorithm: with CHFpEF, with intermediate probability of HF, and without HF (58.9, 31.1, and 10 %, respectively). The study showed that patients with CHFpEF compared to patients of the intermediate group and without HF, had higher levels of brain natriuretic peptide, more pronounced signs of congestion according to results of the bioimpedance vector analysis and a higher liver density according to results of indirect fibroelastometry of the liver, which allowed identification of a group of patients with a high probability of CHFpEF. The diagnosis of HF by HFA-PEFF had an adverse prognostic significance with respect of worsened QoL according to the KCCQ questionnaire, and of repeated admission for HF during a year.

Conclusion      In AH patients with symptoms of HF and LV EF ≥50 %, CHFpEF was detected with the HFA-PEFF algorithm in 58.9 % of cases. Patients with AH and verified CHFpEF had a high incidence of hyperhydration and increased liver density. A diagnosis of CHFpEF by the HFA-PEFF algorithm had an adverse prognostic significance with respect of long-term outcomes.

1. Gerber Y, Weston SA, Redfield MM, Chamberlain AM, Manemann SM, Jiang R et al. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Internal Medicine. 2015;175(6):996–1004. DOI: 10.1001/jamainternmed.2015.0924

2. Devereux RB, Roman MJ, Liu JE, Welty TK, Lee ET, Rodeheffer R et al. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. The American Journal of Cardiology. 2000;86(10):1090–6. DOI: 10.1016/S0002-9149(00)01165-6

3. Vasan RS, Larson, MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. Journal of the American College of Cardiology. 1999;33(7):1948–55. DOI: 10.1016/S0735-1097(99)00118-7

4. Gottdiener JS, McClelland RL, Marshall R, Shemanski L, Furberg CD, Kitzman DW et al. Outcome of Congestive Heart Failure in Elderly Persons: Influence of Left Ventricular Systolic Function: The Cardiovascular Health Study. Annals of Internal Medicine. 2002;137(8):631–9. DOI: 10.7326/0003-4819-137-8-200210150-00006

5. Davis RC, Hobbs FD, Lip GY. ABC of heart failure: History and epidemiology. BMJ. 2000;320(7226):39–42. DOI: 10.1136/bmj.320.7226.39

6. Remes J, Miettinen H, Reunanen A, Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. European Heart Journal.1991;12(3):315–21. PMID: 2040313

7. Tereshchenko S.N., Galyavich A.S., Uskach T.M., Ageev F.T., Arutyunov G.P., Begrambekova Yu.L. et al. 2020 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):311–74. DOI: 10.1016/j.jcmg.2019.01.037

8. Henein MY, Tossavainen E, A’roch R, Söderberg S, Lindqvist P. Can Doppler echocardiography estimate raised pulmonary capillary wedge pressure provoked by passive leg lifting in suspected heart failure? Clinical Physiology and Functional Imaging. 2019;39(2):128–34. DOI: 10.1111/cpf.12547

9. Tossavainen E, Wikström G, Henein MY, Lundqvist M, Wiklund U, Lindqvist P. Passive leg-lifting in heart failure patients predicts exercise-induced rise in left ventricular filling pressures. Clinical Research in Cardiology. 2020;109(4):498–507. DOI: 10.1007/s00392-019-01531-w

10. Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E et al. How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Heart Journal. 2019;40(40):3297–317. DOI: 10.1093/eurheartj/ehz641

11. Barandiarán Aizpurua A, Sanders‐van Wijk S, Brunner‐La Rocca H, Henkens M, Heymans S, Beussink‐Nelson L et al. Validation of the HFA‐PEFF score for the diagnosis of heart failure with preserved ejection fraction. European Journal of Heart Failure. 2020;22(3):413–21. DOI: 10.1002/ejhf.1614

12. Sun Y, Wang N, Li X, Zhang Y, Yang J, Tse G et al. Predictive value of H2 FPEF score in patients with heart failure with preserved ejection fraction. ESC Heart Failure. 2021;8(2):1244–52. DOI: 10.1002/ehf2.13187

13. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895–1032. DOI: 10.1161/CIR.0000000000001063

14. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. Journal of the American College of Cardiology. 2000;35(5):1245–55. DOI: 10.1016/S0735-1097(00)00531-3

15. Joseph SM, Novak E, Arnold SV, Jones PG, Khattak H, Platts AE et al. Comparable Performance of the Kansas City Cardiomyopathy Questionnaire in Patients With Heart Failure With Preserved and Reduced Ejection Fraction. Circulation: Heart Failure. 2013;6(6):1139–46. DOI: 10.1161/CIRCHEARTFAILURE.113.000359

16. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA. Doppler Tissue Imaging: A Noninvasive Technique for Evaluation of Left Ventricular Relaxation and Estimation of Filling Pressures. Journal of the American College of Cardiology. 1997;30(6):1527–33. DOI: 10.1016/S0735-1097(97)00344-6

17. European Association for Study of Liver. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. Journal of Hepatology. 2015;63(1):237–64. DOI: 10.1016/j.jhep.2015.04.006

18. Obokata M, Negishi K, Kurosawa K, Arima H, Tateno R, Ui G et al. Incremental Diagnostic Value of LA Strain With Leg Lifts in Heart Failure With Preserved Ejection Fraction. JACC: Cardiovascular Imaging. 2013;6(7):749–58. DOI: 10.1016/j.jcmg.2013.04.006

19. Triposkiadis F, Giamouzis G, Parissis J, Starling RC, Boudoulas H, Skoularigis J et al. Reframing the association and significance of comorbidities in heart failure: Co-morbidities in heart failure. European Journal of Heart Failure. 2016;18(7):744–58. DOI: 10.1002/ejhf.600

20. Saito Y, Kato M, Nagashima K, Monno K, Aizawa Y, Okumura Y et al. Prognostic Relevance of Liver Stiffness Assessed by Transient Elastography in Patients With Acute Decompensated Heart Failure. Circulation Journal. 2018;82(7):1822–9. DOI: 10.1253/circj.CJ-17-1344

21. Soloveva A.E., Kobalava Zh.D., Villevalde S.V., Bayarsaikhan M., Garmash I.V., Fudim M. Prognostic value of liver stiffness in decompensated heart failure: results of prospective observational transient elastography-based study. Kardiologiia. 2018;17(S10):20–32. DOI: 10.18087/cardio.2488

22. Santarelli S, Russo V, Lalle I, De Berardinis B, Vetrone F, Magrini L et al. Prognostic value of decreased peripheral congestion detected by Bioelectrical Impedance Vector Analysis (BIVA) in patients hospitalized for acute heart failure: BIVA prognostic value in acute heart failure. European Heart Journal: Acute Cardiovascular Care. 2017;6(4):339–47. DOI: 10.1177/2048872616641281

23. Selvaraj S, Myhre PL, Vaduganathan M, Claggett BL, Matsushita K, Kitzman DW et al. Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community. JACC: Heart Failure. 2020;8(8):640–53. DOI: 10.1016/j.jchf.2020.03.013

24. Sotomi Y, Iwakura K, Hikoso S, Inoue K, Onishi T, Okada M et al. Prognostic significance of the HFA‐PEFF score in patients with heart failure with preserved ejection fraction. ESC Heart Failure. 2021;8(3):2154–64. DOI: 10.1002/ehf2.13302